Source: Softengi Blog

Softengi Blog AI for Drug Safety Use Cases

Drug safety and revealing drug adverse effects have always been a priority in the healthcare service. It increased in Covid and post-Covid times with the tensions around vaccine safety. AI solutions developers are convinced that AI can find new adverse drug effects much faster and more effectively than people do while significantly increasing drug safety. [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Gennadiy Axion's photo - CEO of Softengi

CEO

Gennadiy Axion

CEO Approval Rating

72/100

Read more